<<“Virtual” biotech companies typically consist of one or two Kool-Aid-drinking founder-executives and some drug candidates that no one else wanted. The track record of these companies in getting drugs approved for marketing or getting them partnered on favorable economic terms is so dismal that you’d probably have better odds betting on Estonia to win the most medals of any country at the next Olympics.>>
No argument with that as a circular definition that doubtless fits many examples! The problem comes in applying it to one or two cases where the 'kool-aid' and 'unwanted' qualifiers are debatable, to say the least.